The Bangasafe Oro-Nasal Spray has proven safe, effective and helpful in reducing the viral load in a small trial, according to the government institute. If sprayed after 3-4 hours, our solution can eliminate the virus in the nose, nasal cavity, oral cavity and those at the joint of respiratory digestive tracts,” said Dr Mala Khan, acting director general of BRICM. She highlighted two benefits of the spray – it can kill the virus in close contacts of COVID-19 patients and reduce the viral load of the patients. This was the first time a nasal spray against the novel coronavirus, SARS-CoV-2, underwent human trial in the world, Mala claimed. France held a trial on a similar spray on five people only after the Bangladeshi institute conducted its trial, she added.

Source: bd News24 January 12, 2021 14:25 UTC